tru Independence’s Fulgent Genetics FLGT Stock Holding History

tru Independence’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-625	Closed	-$10	–	523
2020 Q2	$10	Buy	+625	New	+$9.57K	﹤0.01%	586

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RJT

Raymond James Trust St. Petersburg, Florida $4.6B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OWIM

Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

tru Independence's FLGT Position: Q3 2020 in Review

tru Independence sold out of Fulgent Genetics (FLGT) in Q3 2020, closing a stake of 625 shares — an estimated $10 sold.

tru Independence first reported a position in FLGT in Q2 2020 and held it in 1 quarter. The position peaked at $10 in Q2 2020. 126 funds tracked by Wall St. Rank hold FLGT as of Q3 2020.

tru Independence reported no remaining Fulgent Genetics position as of Q3 2020 after selling out during the quarter.
tru Independence sold 625 Fulgent Genetics shares in Q3 2020, an estimated $10.
tru Independence first reported a position in Fulgent Genetics in Q2 2020 and held it in 1 quarter.
tru Independence's Fulgent Genetics position peaked at $10 in Q2 2020.
126 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2020.

Based on tru Independence's 13F filing for Q3 2020, filed 19 Nov 2020.